{name}
{subtitle}
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~17 mi. (Winterthur, Switzerland, +199 more cities)
facility
Kantonsspital Winterthur ( Site 0714)
Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)
city
~31 mi. (Sankt Gallen, Switzerland, +28 more cities)
facility
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 2502)
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Investigational Agents for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)
city
~31 mi. (Sankt Gallen, Switzerland, +27 more cities)
facility
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 3502)
drug
favezelimab, +4 more drugs
drug type
immunotherapy, +1 more type
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)
city
~31 mi. (Sankt Gallen, Switzerland, +34 more cities)
facility
Cantonal Hospital St.Gallen-Klinik für Gastroenterologie / Hepatologie ( Site 0334)
drug
lenvatinib, +2 more drugs
drug type
immunotherapy, +1 more type
Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug
city
~31 mi. (Sankt Gallen, Switzerland, +15 more cities)
facility
Kantonsspital St. Gallen
biomarker
ARID1A Loss, +125 more biomarkers
drug
elimusertib, +1 more drug
drug type
immunotherapy, +1 more type
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~33 mi. (Zürich, Switzerland, +150 more cities)
facility
Universitaetsspital Zurich ( Site 1923)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~33 mi. (Zürich, Switzerland, +145 more cities)
facility
Universitaetsspital Zuerich ( Site 1700)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~33 mi. (Zürich, Switzerland, +127 more cities)
facility
Universitätsspital Zürich /ID# 215891
drug
azacitidine, +2 more drugs
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
city
~33 mi. (Zürich, Switzerland, +105 more cities)
facility
Universitaetsspital Zuerich ( Site 1400)
biomarker
ATM Loss, +62 more biomarkers
condition
Breast Carcinoma, +2 more conditions